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Firefly luciferase-catalyzed light emission from
D-luciferin is widely used as a reporter of gene
expression and enzymatic activity both in vitro and
in vivo. Despite the power of bioluminescence for
imaging and drug discovery, light emission from
firefly luciferase is fundamentally limited by the phys-
ical properties of the D-luciferin substrate. We and
others have synthesized aminoluciferin analogs that
exhibit light emission at longer wavelengths than
D-luciferin and have increased affinity for luciferase.
However, although these substrates can emit an
intense initial burst of light that approaches that of
D-luciferin, this is followed by much lower levels of
sustained light output. Here we describe the crea-
tion of mutant luciferases that yield improved sus-
tained light emission with aminoluciferins in both
lysed and live mammalian cells, allowing the use
of aminoluciferins for cell-based bioluminescence
experiments.
INTRODUCTION
Light emission from firefly luciferase is fundamentally limited by
its access to D-luciferin and the inherent photophysical proper-
ties of the D-luciferin substrate (Figure 1A) (Reddy et al., 2010).
Replacement of the 60-hydroxyl group of D-luciferin with a
60-amino group results in red-shifted light emission (White
et al., 1966) and higher affinity for luciferase, but lower maximal
light emission and lower cell-permeability (Shinde et al., 2006).
Although D-luciferin is the superior substrate for maximal light
emission under most conditions, the unique chemistry of
60-aminoluciferin has expanded the scope of luciferase appli-
cations. For example, the liberation of 60-aminoluciferin from
‘‘dark’’ proluciferin protease substrates has been exploited to
allow the coupled bioluminescent detection of protease activity,
both in vitro (Monsees et al., 1994; Moravec et al., 2009) and
in vivo (Shah et al., 2005; Dragulescu-Andrasi et al., 2009; Hick-
son et al., 2010; Scabini et al., 2011).
Recently, we and others have reported that 60-alkylaminoluci-
ferins can also be substrates for luciferase (Woodroofe et al.,
2008; Reddy et al., 2010; Takakura et al., 2010). These sub-
strates generally have even higher affinity for luciferase than
60-aminoluciferin and emit light at even longer wavelengths.
Many modifications are tolerated, including long-chain 60-alkyla-Chemistry & Biology 18, 1649–165minoluciferins, 50,60-cyclic alkylaminoluciferins, and even dialky-
laminoluciferins (Figure 1B). Synthetic modulation of the proper-
ties of these molecules thus presents an opportunity to develop
new bioluminescent probes and to optimize luciferase light
output for different applications. However, with wild-type (WT)
Photinus pyralis firefly luciferase, most of these substrates give
a rapid burst of light followed by weak sustained emission
(Reddy et al., 2010).
The detergent-stable proprietary mutant luciferase Ultra-Glo
(Promega) is capable of high sustained light emission with
aminoluciferin substrates, particularly in combination with the
P450-Glo buffer (Woodroofe et al., 2008; Reddy et al., 2010).
The use of aminoluciferins with this luciferase and buffer there-
fore has potential for novel in vitro screening applications, such
as the coupled detection of enzymatic activity (Fan and Wood,
2007). However, Ultra-Glo is a proprietary luciferase reagent
that is not available as a genetic construct that can be expressed
in cells. Furthermore, the detergent stability of Ultra-Glo and the
use of the P450-Glo buffer are important for light emission
behavior. Cellular and in vivo applications such as the detection
of gene expression (de Wet et al., 1987) and bioluminescent
imaging (Prescher and Contag, 2010) necessitate a genetically
encodable luciferase that is capable of efficient utilization of
aminoluciferins under physiological buffer conditions.
We postulated that aminoluciferin substrates possess all of the
key photophysical and structural features necessary to give rise
to bioluminescence, but are primarily limited as luciferase
substrates due to product inhibition (Reddy et al., 2010). Here
we report the construction of mutant luciferases capable of sus-
tained and selective light emission with aminoluciferins, thereby
expanding the available tools for bioluminescence imaging.RESULTS
Rational Mutation of Luciferase
Our initial efforts to improve luciferase light emission with
alkylaminoluciferin substrates focused on rational mutation of
phenylalanine 247 in the luciferin binding pocket. This residue
is involved in a p-stacking interaction with D-luciferin (Branchini
et al., 2003; Nakatsu et al., 2006). Mutation of this residue to
leucine and alanine has been previously reported by Branchini
et al. (2003), who found that F247L lowers the affinity for
D-luciferin but does not impair catalysis, whereas F247A is
severely impaired in both Km and Vmax. We therefore anticipated
that F247L would maintain catalytic function but allow improved
product dissociation, helping to relieve product inhibition and
allowing improvement in the sustained light emission from
alkylaminoluciferin substrates.7, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1649
Figure 1. Luciferase Mechanism and Substrates
(A) Firefly luciferase catalyzes the formation of an activated
AMP ester of its native substrate, D-luciferin. Subsequent
oxidation within the luciferase binding pocket generates
an excited-state oxyluciferin molecule that is responsible
for light emission.
(B) Synthetic alkylated aminoluciferin substrates used in
this study.
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Mutant Luciferases that Utilize AminoluciferinsSurprisingly, we found that the F247L mutation improves
maximal sustained light emission from 60-aminoluciferin by
4.9-fold but has only a small positive effect on light emission
from CycLuc1 (Figure 2; Figure S1 available online). Instead,
we found that the F247A mutation, which has a marked negative
effect on light output from both D-luciferin and 60-aminoluciferin,
gave dramatically improved sustained light output fromCycLuc1
(Figure 2; Figure S1). The improved light output of this mu-
tant comes at the cost of a substantially increased Km value.
Although this is not a concern under conditions where saturating
concentrations of substrate can be applied (e.g., in vitro), a high
Km is expected to limit light output in live cells (Figure S1C),
where only low intracellular concentrations of luciferin substrates
are achieved (deWet et al., 1987; Craig et al., 1991; Shinde et al.,
2006).We therefore sought alternate sites formutation that could
potentially increase light output yet retain a low Km.
Screening for Mutant Luciferases with Improved
Utilization of Aminoluciferins
Because mutation of phenylalanine 247 was found to affect
substrate utilization, but not in an easily predictable manner,
we opted to perform saturating mutagenesis at this and other
active site residues, and then screen for mutant luciferases
with the desired properties. This approach has the advantage
of rational site selection, but is not restricted by preconceived
notions of suitable replacement residues. Based on the crystal
structure of Luciola cruciata luciferase (Nakatsu et al., 2006),
we identified a number of amino acids that interact with D-lucif-
erin or ATP or play a role in creating the overall local structure of
the binding pocket (Figure 3A; Table S1). In addition to phenylal-
anine 247, we selected arginine 218, threonine 251, leucine 286,
tyrosine 340, and serine 347 for saturatingmutagenesis. Arginine
218 is proximal to the 40- and 50-carbons of D-luciferin and forms
part of the van der Waals surface that encompasses the luciferin
substrate (Nakatsu et al., 2006). Mutations at this site were
expected to provide increased ‘‘wiggle room’’ for substrates,
particularly those with 50-modifications (i.e., CycLuc1 and
CycLuc2). Leucine 286 is a candidate residue for interaction
with alkyl side chains on aminoluciferin substrates, whereas1650 Chemistry & Biology 18, 1649–1657, December 23, 2011 ª2011 Elsevier Ltd All rtyrosine 340 forms part of the ATP site and is
located at the interface between the ATP and
luciferin binding pockets. The methyl group of
the threonine 251 side chain engages in a van
der Waals interaction with the benzothiazole of
the luciferin substrate, while serine 347 forms
a hydrogen bond to the benzothiazole nitrogen
through the intermediacy of a water molecule
(Nakatsu et al., 2006). We reasoned that muta-
tion at these sites could potentially lead toimproved continuous light emission from aminoluciferins by
altering substrate alignment and/or improving product dissocia-
tion. Because aminoluciferins have higher affinity for luciferase,
the loss of interactions with the benzothiazole could also confer
selectivity over D-luciferin, particularly if the affinity and proper
orientation of alkylaminoluciferins can be maintained by ancillary
interactions that are not available to D-luciferin.
At each selected site, we used the degenerate codon NNK to
perform saturating site-directedmutagenesis in theWTP. pyralis
luciferase (Figure 3B). At some sites, we also introduced alanine
point mutations (see Experimental Procedures). After cloning of
the mutant luciferases into bacteria, colonies were picked and
grown in 96-well plates (Figure 3B). Luciferase expression was
induced with isopropyl b-D-1-thiogalactopyranoside (IPTG), and
the bacteria were lysed. Light emission from each lysate was
measured at a luciferin concentration of 25 mM. For those lysates
that gave improved and/or selective light output with CycLuc1,
the plasmid encoding the mutant luciferase was sequenced
(Table S1). Mutation at some sites failed to produce any obvious
improvement in luciferase performance. For example, mutation
of tyrosine 340 in the nucleotide binding pocket primarily
yielded inactive luciferases. In hindsight, Y340 participates in a
hydrogen-bonding interaction with D420 that may be critical
for luciferase function (Nakatsu et al., 2006). A secondary assay
was also performed on the bacterial extracts to measure light
output as a function of CycLuc1 concentration (Figure 3B).
Mutants that demonstrated improved light output, low Km,
and/or selectivity for CycLuc1 in this assay were expressed as
recombinant proteins and purified for further characterization.
Characterization of Mutant Luciferases In Vitro
Screening for mutants of phenylalanine 247 identified F247S
and F247V as proteins with greatly improved light output from
CycLuc1, but still with relatively high Km values (Figure 2). Muta-
tions at several of the other chosen sites (R218K, T251S, L286M,
S347T, and S347A) improved light emission with aminoluciferins
while retaining Km values below that of the native substrate
D-luciferin. For these purified mutant luciferases, light output
as a function of substrate concentration was measured withights reserved
Figure 2. Characterization of Phenylalanine 247 Mutants
Dose-response curves for purified luciferases (WT, F247L, F247A, F247S, and
F247V) were generated with D-luciferin, 60-NH2LH2, and CycLuc1 at concen-
trations of 0.122–125 mM. The assays were performed in triplicate and are
represented as the mean ± SEM. Note that the emission scale for D-luciferin is
four-fold higher than that of 60-NH2LH2 and CycLuc1. Comparison of each
mutant in lysed and live CHO cells is detailed in Figure S1.
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Mutant Luciferases that Utilize AminoluciferinsD-luciferin and the aminoluciferin substrates shown in Figure 1B,
with nonlinear regression fitting to the Michaelis-Menten equa-
tion (Figure 4; Table S2). For most of the luciferase mutants,
the rank of light output was D-Luc > CycLuc1 > 60-NH2LH2 >
60-MeNHLH2 > CycLuc2 > 60-Me2NLH2. In all cases, the amino-
luciferins exhibited much lower Km values than D-luciferin. The
R218K mutant was the most generally beneficial mutation,
yielding the greatest light output for most aminoluciferinChemistry & Biology 18, 1649–165substrates, including a 20-fold improvement in the maximal sus-
tained emission from CycLuc2 while retaining a very low Km of
0.3 mM (Figure 4; Table S2). Similarly, themaximal sustained light
emission from CycLuc1 was increased 14-fold to 12.5% of that
of D-luciferin with WT luciferase, yet at a Km of 1.8 mM that is still
substantially lower than that of D-luciferin. The R218K mutation
has been previously described in the context of D-luciferin,
and is known to raise the Km but cause minimal disruption of
catalytic activity (Branchini et al., 2001).
Themost selective luciferasemutants were S347A and S347T.
Because the activity of the purified S347T luciferase was found
to decline rapidly when stored at 4C, S347A was used in prefer-
ence to S347T for further characterization (Figure S2A). The
S347A luciferase yielded a 14-fold increase in light emission
for CycLuc1, equivalent to that of the R218Kmutant, while simul-
taneously decreasing the maximal emission from D-luciferin by
7.5-fold and raising the Km for D-luciferin by >10-fold (Figure 4;
Table S2). To determine whether this selectivity could be further
increased, we created several combinations of the S347A
mutation with T251S, L286M, or F247 mutants (Figure S2B). All
of these mutants showed increased discrimination against
D-luciferin, giving even lower light output than with S347A alone.
On the other hand, the S347A/L286M double mutant further
increased the maximal sustained light emission from CycLuc1
by two-fold relative to S347A alone, albeit with a 10-fold
increase in the Km to 22 mM.
Rapid injection experiments were performed to reveal the
burst kinetic behavior of the mutant luciferases (Figure 5; Fig-
ure S3). As we have observed for the WT protein, most alkylami-
noluciferin substrates gave a rapid initial burst of light, followed
by a substantial decrease in the rate of light output (Reddy
et al., 2010). Most of the mutant luciferases identified here
shared this general behavior, although the decrease in the rate
of light output was less severe than that of theWT protein, result-
ing in a higher level of sustained light emission (Figure 5A; Fig-
ure S3). The most striking finding was that the initial rate of light
output for the dialkylaminoluciferin CycLuc2 with the mutant
R218K is considerably increased relative to the WT protein (Fig-
ure 5B; Figure S3). In contrast, the burst kinetic profile for the
corresponding acyclic dialkylaminoluciferin 60-Me2N-LH2 was
largely unchanged (Figure 5C; Figure S3).
The bioluminescence emission wavelength of aminoluciferins
is red-shifted relative to D-luciferin with all of the tested lucifer-
ases (Table S3). Because the photomultiplier tube (PMT) in the
Turner Veritas plate reader is less sensitive to the red-shifted
light emission of the aminoluciferin substrates than the green
light emission of D-luciferin, this likely leads to an underestima-
tion of the true light output for aminoluciferins. We did not
attempt to correct for this difference, which also varies among
mutants. For example, the R218K luciferase caused a slight
red-shift in the bioluminescence of all luciferins: D-luciferin
yields maximal emission at 567 nm, CycLuc1 at 609 nm, and
CycLuc2 at 621 nm (Table S3). In contrast, the L286M mutant
results in a 5–13 nm blue-shift in the emission of all aminoluci-
ferins, but a diametrically opposed 13 nm red-shift in D-luciferin
light emission (Table S3). Interestingly, the S347A mutant
gives discrete emission peaks for all of the aminoluciferins,
but anomalous bimodal emission for D-luciferin (Branchini
et al., 2003).7, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1651
Figure 3. Creation of Mutant Luciferases
(A) Mutation sites were selected based on proximity to the luciferin substrate in the crystal structure of Luciola cruciata luciferase (PDB 2D1R).
(B) Selected residueswere subjected to saturatingmutagenesis.Mutant luciferase-expressing bacteria were screened for light emission with CycLuc1; those that
exhibited improved properties were sequenced (Table S1), and the mutant protein was purified for further characterization.
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Mutant Luciferases that Utilize AminoluciferinsCharacterization of Mutants in Mammalian Cells
The mutant luciferases that performed best in vitro were cloned
into pcDNA3.1 and transfected into CHO-K1 cells. Light emis-
sion from mutant luciferases in CHO cell lysates generally
mirrored the results with purified proteins (Figures 2 and 4;
Figures S1 and S4). The lone exception was L286M, which
gave lower light output than expected, possibly indicating that
this protein has a lower expression level and/or stability in the
cellular context (Figure 4; Figure S4). Unsurprisingly, D-luciferin
was the best substrate for WT luciferase (Figure 6A). However,
for the R218K and T251S mutant luciferases, CycLuc1 light
output was superior to D-luciferin at substrate concentrations
below 30 mM. In the case of the S347A mutant, CycLuc1 ex-
ceeded the light output of D-luciferin over the entire concentra-
tion range (Figure 6A). All other substrates had considerably
lower levels of light emission in cell lysates, with the exception
of 60-aminoluciferin with the mutant F247L (Figure S1B).
The light output from luciferase in live cells is much lower than
that of lysed cells, as has been previously observed for D-lucif-
erin (de Wet et al., 1987; Craig et al., 1991; Shinde et al., 2006)
and 60-aminoluciferin (Shinde et al., 2006). Moreover, there is
less difference in the relative levels of light emission between
different substrates. Even with the WT luciferase, CycLuc11652 Chemistry & Biology 18, 1649–1657, December 23, 2011 ª2011emitted 26% of the light of D-luciferin at 125 mM, and its light
output exceeded that of 60-aminoluciferin (Figure 6B). CycLuc1
was the superior substrate for T251S, R218K, and particularly
S347A luciferase (18-fold higher light output than D-luciferin at
125 mM). Remarkably, live-cell light emission from CycLuc2
exceeded that of both CycLuc1 and D-luciferin with T251S,
S347A, and particularly R218K luciferase over a broad concen-
tration range, despite the relatively poor light output from
CycLuc2 in cell lysates (Figure 6).
DISCUSSION
We have found that mutation of firefly luciferase can dramatically
improve aminoluciferin substrate utilization and selectivity, and
allow the use of these substrates to monitor luciferase expres-
sion in cells and cell lysates. For example, the F247L mutant
improves light output from 60-aminoluciferin by almost five-fold
and can be recommended for improved imaging of this substrate
(Figure 2; Figure S1). This has particular significance for biolumi-
nescence assays of protease activity that rely on detection of this
substrate (Monsees et al., 1994; Shah et al., 2005; Fan and
Wood, 2007; Dragulescu-Andrasi et al., 2009; Hickson et al.,
2010; Scabini et al., 2011). Light output from all aminoluciferinsElsevier Ltd All rights reserved
Figure 4. Characterization of Luciferase
Mutants
Dose-response curves for purified luciferases (WT,
T251S, L286M, S347A, andR218K) are shownwith
each luciferin substrate. The assays were per-
formed in triplicate and are represented as the
mean ± SEM. The y axes have been calibrated to
allow comparison of mutant emission for each
substrate. For comparison between substrates,
note the difference in scale. Each curve was fit to
the Michaelis-Menten equation by nonlinear re-
gression (GraphPad 5.0) to determine apparent
Km and Vmax values (Table S2). Comparison of the
light emission of S347T and S347A and the com-
bination of S347A with other mutations is detailed
in Figure S2.
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Mutant Luciferases that Utilize Aminoluciferinswas greatly increased by the R218K mutant (e.g., 14-fold for
CycLuc1, 20-fold for CycLuc2), suggesting thismutant as a start-
ing point for measuring light emission from these and other novel
alkylated aminoluciferins. Moreover, mutation of serine 347 to
threonine or alanine gives similarly improved light emission
from CycLuc1 but also exhibits strong selectivity for CycLuc1
over D-luciferin both in vitro and in live cells (Figures 4 and 6;
Figures S2 and S4). Combination of mutations such as the
ones described here is expected to allow further enhancement
of aminoluciferin light output and selectivity. For instance, we
have found that the S347A/L286M double mutant gives twice
the light output of S347Awith CycLuc1, and further discriminates
against D-luciferin (Figure S2B).
The rate at which light is generated by luciferase is dependent
on several factors, including the rate of adenylation and oxida-
tion to afford the oxyluciferin excited state, the quantum yield
of light emission, and the rate of product release. To gain insight
into the underlying mechanisms by which light emission from
aminoluciferins is improved with these luciferase mutants, we
monitored the rate of light output over the first 50 s following
substrate addition (Figure 5; Figure S3). For CycLuc1 and
60-MeNH-LH2, all mutants result in a rapid initial burst that is
similar to that observed for the WT protein (Reddy et al., 2010),
suggesting that there are no substantive improvements in the
ability to form the respective luciferyl-AMP, its subsequentChemistry & Biology 18, 1649–1657, December 23, 2011 ªoxidation to afford the excited-state oxy-
luciferin, or the quantum yield of light
emission. Rather, higher light output was
observed after the initial burst (Figure 5A;
Figure S3), implicating a reduction in
product inhibition as the primary factor
responsible for the observed improve-
ment in sustained light emission. Even
with D-luciferin, the molecular basis for
product inhibition is still unresolved,
potentially including contributions from
both dehydroluciferyl-AMP (L-AMP) and
oxyluciferin (Fraga, 2008). Lowered pro-
duct inhibition could result from a simple
reduction in affinity for aminoluciferin
substrates and their corresponding prod-
ucts. Alternatively, it is possible that somemutants function in part by reducing the formation of the corre-
sponding L-AMP analog. A better molecular understanding of
the nature of the product inhibition with these substrates may
help guide future optimization efforts.
Notably, both the burst and sustained light emission from
CycLuc1 exceeds that of 60-MeNH-LH2 with all of the luciferases
we have characterized, and is consistent with a role for cycliza-
tion in optimizing aminoluciferin light output (Reddy et al., 2010).
Like CycLuc1, light emission from CycLuc2 is superior to its
acyclic counterpart 60-Me2N-LH2 for every luciferase we have
tested. In contrast to CycLuc1, we find that the burst emission
with CycLuc2 is substantially more rapid and intense with the
mutant luciferase R218K than with WT (Figure 5B; Figure S3),
indicating an improvement in one or more of the enzymatic steps
required to form this excited-state oxyluciferin (e.g., adenylation
and/or oxidation). We postulate that the bulk and rigidity of
CycLuc2 enforces a suboptimal alignment for the production
of the excited-state oxyluciferin in the WT luciferase. Enlarging
the luciferin binding pocket with the R218K mutation improves
the alignment of CycLuc2 within the active site, allowing more
rapid production of an efficient light-emitting oxyluciferin excited
state (Figure 5B). By comparison, the more flexible substrate
60-Me2N-LH2 gives a rapid but weak burst for all mutants (Fig-
ure 5C; Figure S3). We hypothesize that the free bond rotation
about the aryl amine bond of 60-Me2N-LH2 can facilitate the2011 Elsevier Ltd All rights reserved 1653
Figure 5. Burst Kinetic Profiles with WT and R218K Luciferases
(A–C) Purified luciferases (10 nM) were rapidly injected at the 10 s time point
into 10 mM of CycLuc1 (A), CycLuc2 (B), or 60-Me2NLH2 (C), and the light
emission was recorded. Burst emission behavior for all substrates and char-
acterizedmutants is detailed in Figure S3, with emission wavelengths reported
in Table S3.
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Mutant Luciferases that Utilize Aminoluciferinsalignment necessary for the rapid formation of the oxyluciferin
but also limits the efficiency of light output from this excited-state
molecule (Figure 5C).
For light emission from live cells, the cell permeability and Km
of the substrate are important for access to the intracellular lucif-
erase and the efficiency of light output under subsaturating con-
centrations. CycLuc2 has a lower Km than CycLuc1 (Table S2)
and is predicted to be more cell-permeable than CycLuc1
because of the replacement of a polar amine protonwith amethyl
group (cLogP of 2.5 versus 2.0). These differences are therefore
likely to explain the better relative performance of CycLuc2 in live
versus lysed cells (Figure 6). Moreover, this suggests that optimi-
zation of cell permeability and light output at low substrate
concentrations—rather than just maximal light output—may be
particularly important for imaging in live cells and organisms,1654 Chemistry & Biology 18, 1649–1657, December 23, 2011 ª2011because insufficient substrate is delivered into the live cell to
achieve maximal light emission.
The bioluminescence emission wavelength of D-luciferin from
different beetle luciferases (firefly, click beetle, railroad worm)
and their mutants ranges from 540 to 622 nm (Viviani et al.,
1999; Branchini et al., 2010). Beyond simple changes in the
polarity of the environment of the light emitter (Morton et al.,
1969), explanations for this sensitivity include the rigidity of the
active site (Nakatsu et al., 2006) and perturbations in the ionic
interactions of the phenolate of D-luciferin (Hirano et al., 2009).
The emission behavior of aminoluciferins can lend insight into
this question because they lack an ionizable phenolate (Figure 1).
With the mutant R218K, all luciferins exhibit a modest red-shift in
emission wavelength (Table S3). Because oxyluciferins are
asymmetric charge-transfer molecules, some shared solvato-
chromatic sensitivity to the polarity of the luciferin binding site
is expected (Naumov et al., 2009). However, D-luciferin exhibits
anomalous emission behavior with several mutants: the L286M
mutation causes a red-shift in the emission of D-luciferin but
a blue-shift in the emission of all aminoluciferins, and D-luciferin
uniquely gives bimodal emission with S347A (Table S3). These
differences are consistent with a role for the ionization state
and ionic interactions of the phenol in determining the biolumi-
nescence emissionwavelength whenD-luciferin is the substrate.
The efficient chemical generation of light by firefly luciferase
has been widely used as a sensitive reporter system for gene
expression (de Wet et al., 1987; Prescher and Contag, 2010).
However, the application of bioluminescence detection as a
general optical reporter of cellular status has lagged behind
that of fluorescence. Chemical modification of the luciferin
substrate can red-shift the emission wavelength of biolumines-
cence beyond that of D-luciferin (Reddy et al., 2010). Moreover,
the combination of synthetic luciferins and mutant luciferases
described here not only extends the wavelength of biolumines-
cence emission and broadens the scope of substrates that can
be used for bioluminescent assays both in vitro and in mamma-
lian cells, but also suggests that orthogonal luciferases could
be developed to allow multiplexing of bioluminescent signals.
Further chemical modification of luciferin substrates and corre-
sponding mutation of firefly and other beetle luciferases is there-
fore anticipated to be a fruitful avenue for expanding the power
and scope of bioluminescence assays and imaging.
SIGNIFICANCE
Aminoluciferin, in which the 60-hydroxyl group of D-luciferin
is replaced by a 60-amino group, is a firefly luciferase sub-
strate that is widely used for bioluminescent protease
assays. Recently, we and others have discovered that a
wide variety of modifications of the 60-amino group retain
bioluminescent light emission, including alkylation of the
60-amino group and 50,60-fused ring structures. This family
of synthetic aminoluciferin substrates exhibits desirable
properties such as light emission at longer wavelengths
than D-luciferin and increased affinity for luciferase, but is
limited by low sustained light output after an initial flash of
light. Here we have described the creation of mutant lucifer-
ases that yield improved sustained light emission with ami-
noluciferins, both in vitro and in lysed and live mammalianElsevier Ltd All rights reserved
Figure 6. Dose-Response Profiles from
Luciferases Expressed in CHO-K1 cell
lysates and in live cells
(A and B) CHO-K1 cells were transiently trans-
fected with pcDNA3.1 vectors expressing WT,
T251S, L286M, S347A, or R218K firefly luciferase.
Dose-response curves for each luciferase with
D-luciferin, 60-NH2LH2, 60-MeNHLH2, 60-Me2NLH2,
CycLuc1, and CycLuc2 were generated at con-
centrationsof 0.122–125 mMusing lysates from the
transfected cells (A) or using the intact live cells (B).
The assays were performed in triplicate and are
represented as the mean ± SEM. Note that the WT
emission scale is larger than that of the mutants by
two-fold and three-fold for cell lysates and live
cells, respectively. Substrate-by-substrate com-
parison of the light emission from each mutant in
cell lysates is detailed in Figure S4.
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Mutant Luciferases that Utilize Aminoluciferinscells. Light output from 60-aminoluciferin is greatly in-
creased with the luciferase mutant F247L, which has impli-
cations for the use of this substrate in bioluminescent
protease assays. The luciferasemutant R218K gives broadly
improved light output with a wide variety of aminoluciferins,
including monoalkylated, dialkylated, and cyclic aminoluci-
ferin substrates. Significant discrimination between luciferin
substrates was observed for manymutants, suggesting that
orthogonal luciferases could be developed to allow multi-
plexing of bioluminescent signals. For example, the cyclic
alkylaminoluciferin CycLuc1 is a better substrate for S347A
luciferase than D-luciferin. Aminoluciferins possess unique
physical and photophysical properties that have yet to be
fully exploited in bioluminescent assays and imaging, and
these mutant luciferases broaden the scope and utility of
their application.
EXPERIMENTAL PROCEDURES
Materials
Chemicals for synthesis were obtained from Aldrich unless otherwise noted.
Data were plotted with GraphPad Prism 5.0. Nuclear magnetic resonance
(NMR) spectra were recorded on a Varian Mercury 400 MHz NMR spectrom-
eter. Small molecule mass spectral data were recorded on a Waters QTOF
Premier spectrometer. Protein structures were displayed with ICM-Browser
(MolSoft). Bioluminescence measurements were taken in a Turner Veritas
luminometer and were not corrected for differences in the wavelength sensi-
tivity of the PMT. Emission spectra and burst kinetic data measurements
were recorded on a Spex FluoroMax-3 fluorimeter. D-luciferin was obtained
from Anaspec and 60-aminoluciferin was obtained fromMarker Gene Technol-
ogies Inc. CycLuc1, CycLuc2, 60-MeNH-LH2, and 60-Me2NLH2 were synthe-
sized as previously described (Reddy et al., 2010). Protein concentrations
were determined using Coomassie Plus (Thermo Scientific). Immobilized
glutathione (Thermo Scientific) was used for glutathione S-transferase
(GST)-tagged protein purification. Unless otherwise stated, all protein purifica-
tion steps were performed at 4C.
Plasmid Constructs
The P. pyralis firefly luciferase gene was PCR-amplified from pGL3 (Promega)
and cloned into the BamHI and NotI sites of pGEX6P-1 for bacterial ex-
pression. Mutant proteins were created using the Quickchange site-directed
mutagenesis kit (Stratagene). Saturating mutagenesis was performed at sites
predicted to impact or alter substrate binding, including: F247, T251, L286,
S347, R337, R218, Y340, and I351, using the degenerate codon NNK. The
point mutants S347A, L286A, A348G, E311A, I351A, and R337A were made
independently.
Mutant Screening
Screening for mutant luciferases was performed in the Escherichia coli strain
JM109, which has high transformation efficiency and plasmid recovery, as
well as reasonable levels of inducible protein expression. Other bacterial
strains [OMNI, DH5a, BL21(DE3), XL1Blue, XL10Gold] yielded less consistent
results. Following saturating mutagenesis, 500 ml of the E. coli strain JM109
was transformed and plated on 5 Luria-Bertani (LB) plates that contained
50 mg/ml carbenicillin. Colonies were picked and used to inoculate two
96-well plates where each well contained 150 ml of LB with 50 mg/ml carbeni-
cillin. Inoculated plates were incubated at 37C overnight. Cells were induced
with 0.1 mM IPTG and incubated at room temperature (RT) overnight. Five ml of
the bacterial protein extraction reagent SoluLyse (Genlantis) was then added
to 50 ml of induced cells followed by a 10 min incubation at RT. Two microliters
of lysate was then added to 60 ml of a solution containing 25 mM substrate in
20 mM Tris (pH 7.6), 0.1 mM EDTA, 8 mM MgSO4, 4 mM ATP, and 1 mM
tris(2-carboxyethyl)phosphine (TCEP) in each well of a white 96-well plate
(Costar 3912). The bioluminescence emission was measured in a Turner
Veritas luminometer after a delay of 2–5 min. Readings were taken every1656 Chemistry & Biology 18, 1649–1657, December 23, 2011 ª201130 s for a total of 10 runs. Mutant lysates that displayed improved and/
selective light emission for CycLuc1 at 25 mMwere then used to measure light
output as a function of CycLuc1 concentration ranging from 0.122 to 250 mM.
These validated mutants were sequenced and subjected to further character-
ization as described below.
Protein Expression
Mutant luciferases were expressed as GST-fusion proteins from the vector
pGEX6P-1 in the E. coli strain JM109. Cells were grown at 37C until the
OD600 reached 0.5–1, induced with 0.1 mM IPTG, and incubated at 20
C over-
night. Cells were pelleted at 5000 rpm in a Sorvall 2C3CPlus centrifuge (H600A
rotor) at 4C for 10 min, then flash-frozen in liquid nitrogen and purified
immediately or stored at 80C.
Luciferase Purification
E. coli cell pellets from 1 l of culture were thawed on ice, resuspended in 25 ml
lysis buffer (50 mM HEPES [pH 7.4], 500 mM NaCl, and 0.5% Tween 20) con-
taining 1 mM phenylmethylsulfonyl fluoride, and disrupted by sonification
(Branson Sonifier). Dithiothreitol (DTT) was added at 10 mM, and the resulting
cell lysate was clarified by centrifugation at 35,000 rpm in a Beckman 50.2 Ti
rotor for 30–45 min. The supernatant was batch-bound to immobilized gluta-
thione for 1 hr at 4C, and the beads were washed with lysis buffer containing
10 mM DTT, followed by wash buffer (50 mM Tris [pH 8.1], 250 mM NaCl and
10 mM DTT) and storage buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1 mM
TCEP). Twenty units of PreScission Protease (GE Healthcare) were added,
and incubation continued for 4 h or overnight at 4C to cleave the GST-fusion
and elute the untagged luciferase protein.
Substrate Dose-Response Assays with Purified Protein
Luminescence assays were initiated by adding 30 ml 23 substrate in either
buffer A (20 mM Tris [pH 7.6], 0.1 mM EDTA, 8 mM MgSO4, 4 mM ATP, and
1 mM TCEP) or buffer B (20 mM Tris [pH 7.6], 0.1 mM EDTA, 8 mM MgSO4,
4 mM ATP, 6 mg/mL bovine serum albumin [BSA], and 33 mM DTT) to 30 ml
of 20 nM purified luciferase in 20 mM Tris (pH 7.6), 0.1 mM EDTA, 1 mM
TCEP and 0.4 mg/mL BSA in a white 96-well plate (Costar 3912). Measure-
ments were performed 3 min after substrate addition in a Turner Veritas lumin-
ometer with final substrate concentrations ranging from 0.122 to 125 mM.
Cell Culture
Chinese hamster ovary-K1 (CHO-K1) cells were grown in a CO2 incubator at
37C with 5% CO2 and were cultured in F-12K Nutrient Mixture (GIBCO) sup-
plemented with 10% fetal bovine serum and 100 U/mL penicillin/streptomycin.
Transfections
Mutant luciferases F247A, F247L, F247V, F247S, T251S, L286M, S347A,
S347T, and R218K were cloned into the BamHI-NotI site of pcDNA 3.1 and
transfected into CHO-K1 cells for live and lysed cell experiments. Transient
transfections were performed at RT using Lipofectamine 2000 on cells plated
at 60%–75% confluency in 96-well white tissue culture-treated plates (Costar
3917) for intact cell assays, or 6-well plates for lysed cell assays. For intact
cells, 0.075 mg DNA/well was transfected; for lysed cells, 2.25 mg DNA/well
was transfected. Assays were performed in triplicate 24 hr after transfection.
Intact Cell Assays
Transfected CHO cells were washed with Hank’s balanced salt solution
(HBSS) and overlaid with 60 ml substrate in HBSS. Titration assays were per-
formed 3min after substrate addition in a Turner Veritas luminometer, with final
substrate concentrations ranging from 0.122 to 125 mM.
Lysed Cell Assays
Transfected CHOcells were washedwith HBSS and lysed for 10min at RTwith
1 ml 13 passive lysis buffer (Promega) per well. Cells from one and a half wells
of a 6-well plate were used to test one substrate in triplicate at the 12 con-
centrations tested. Luminescence assays were initiated by adding 30 ml 23
substrate in 20 mM Tris (pH 7.6), 0.1 mM EDTA, 8 mM MgSO4, 4 mM ATP,
6mg/mL BSA, and 33mMDTT to 30 ml of lysate in a white 96-well plate (Costar
3912). Titration assays were performed 3 min after substrate addition inElsevier Ltd All rights reserved
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Mutant Luciferases that Utilize Aminoluciferinsa Turner Veritas luminometer, with final substrate concentrations ranging from
0.122 to 125 mM.
Bioluminescence Emission Scans and Burst Kinetics Assays
Each purified protein in 20 mM Tris (pH 7.6), 0.1 mM EDTA, 1 mM TCEP and
0.4 mg/mL BSA was added to 23 substrate in 20 mM Tris (pH 7.6), 0.1 mM
EDTA, 8 mM MgSO4, 4 mM ATP, and 1 mM TCEP in a cuvette. Final protein
concentrations were 10 nM, and final substrate concentrations were 10 mM.
Bioluminescence Emission Scans
Luciferase was rapidly injected into a cuvette containing substrate, and the
emission from 400 to 800 nmwas recorded in a SPEX FluoroMax-3 fluorimeter
with closed excitation slits 10 s after injection.
Burst Kinetics Assays
Measurements were taken in a Spex FluoroMax-3 fluorimeter every second
with a 0.1 s integration time at the maximal emission wavelength for each
luciferase/substrate pair. Ten seconds after commencing the assay, protein
was rapidly injected into the cuvette containing substrate to observe both
the burst and the steady-state light emission over the first minute.
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